IRRAF
Irras AB

1
Mkt Cap
$181.75M
Volume
0.00
IRRAF Fundamentals
Loading...
Loading...
Irras AB engages in the development, design, and commercialization of solutions for the treatment of brain pathologies. It offers IRRAflow, an integrated, closed-circuit medical device system that enables controlled management of cerebrospinal fluid (CSF) while providing continual monitoring of intracranial pressure (ICP). The company was founded by Christos Panotopoulos in 2012 and is headquartered in Stockholm, Sweden.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Irras AB?

Latest IRRAF News

View
No IRRAF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.